These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
306 related articles for article (PubMed ID: 31355308)
1. Does time equal vision in the acute treatment of a cohort of AQP4 and MOG optic neuritis? Stiebel-Kalish H; Hellmann MA; Mimouni M; Paul F; Bialer O; Bach M; Lotan I Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e572. PubMed ID: 31355308 [TBL] [Abstract][Full Text] [Related]
2. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 4: Afferent visual system damage after optic neuritis in MOG-IgG-seropositive versus AQP4-IgG-seropositive patients. Pache F; Zimmermann H; Mikolajczak J; Schumacher S; Lacheta A; Oertel FC; Bellmann-Strobl J; Jarius S; Wildemann B; Reindl M; Waldman A; Soelberg K; Asgari N; Ringelstein M; Aktas O; Gross N; Buttmann M; Ach T; Ruprecht K; Paul F; Brandt AU; J Neuroinflammation; 2016 Nov; 13(1):282. PubMed ID: 27802824 [TBL] [Abstract][Full Text] [Related]
3. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B; J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206 [TBL] [Abstract][Full Text] [Related]
4. Factors influencing intravenous methylprednisolone pulse therapy in Chinese patients with isolated optic neuritis associated with AQP4 antibody-seropositive neuromyelitis optica. Guo S; Jiang H; Jiang L; Peng J; Liu H; Wang J; Wei W Sci Rep; 2021 Nov; 11(1):22229. PubMed ID: 34782653 [TBL] [Abstract][Full Text] [Related]
5. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial. Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571 [TBL] [Abstract][Full Text] [Related]
6. Population-Based Incidence of Optic Neuritis in the Era of Aquaporin-4 and Myelin Oligodendrocyte Glycoprotein Antibodies. Hassan MB; Stern C; Flanagan EP; Pittock SJ; Kunchok A; Foster RC; Jitprapaikulsan J; Hodge DO; Bhatti MT; Chen JJ Am J Ophthalmol; 2020 Dec; 220():110-114. PubMed ID: 32707199 [TBL] [Abstract][Full Text] [Related]
7. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients. Bouzar M; Daoudi S; Hattab S; Bouzar AA; Deiva K; Wildemann B; Reindl M; Jarius S J Neurol Sci; 2017 Oct; 381():240-244. PubMed ID: 28991690 [TBL] [Abstract][Full Text] [Related]
8. Prognostic factors of first-onset optic neuritis based on diagnostic criteria and antibody status: a multicentre analysis of 427 eyes. Min YG; Moon Y; Kwon YN; Lee BJ; Park KA; Han JY; Han J; Lee HJ; Baek SH; Kim BJ; Kim JS; Park KS; Kim NH; Kim M; Nam TS; Oh SI; Jung JH; Sung JJ; Jang MJ; Kim SJ; Kim SM J Neurol Neurosurg Psychiatry; 2024 Jul; 95(8):753-760. PubMed ID: 38418215 [TBL] [Abstract][Full Text] [Related]
9. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin. Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M; J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675 [TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China. Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802 [TBL] [Abstract][Full Text] [Related]
11. Antibodies to aquaporin 4, myelin-oligodendrocyte glycoprotein, and the glycine receptor α1 subunit in patients with isolated optic neuritis. Martinez-Hernandez E; Sepulveda M; Rostásy K; Höftberger R; Graus F; Harvey RJ; Saiz A; Dalmau J JAMA Neurol; 2015 Feb; 72(2):187-93. PubMed ID: 25506781 [TBL] [Abstract][Full Text] [Related]
12. Details and outcomes of a large cohort of MOG-IgG associated optic neuritis. Chen JJ; Flanagan EP; Bhatti MT; Tisavipat N; Jamali S; Kunchok A; Eggenberger ER; Nome MD; Sotirchos ES; Vasileiou ES; Henderson AD; Arnold AC; Bonelli L; Seleme N; Mejia-Vergara AJ; Moss HE; Padungkiatsagul T; Stiebel-Kalish H; Lotan I; Wilf-Yarkoni A; Hellmann MA; Vuppala A; Hodge D; Pittock SJ Mult Scler Relat Disord; 2022 Dec; 68():104237. PubMed ID: 36252317 [TBL] [Abstract][Full Text] [Related]
13. Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study. Stiebel-Kalish H; Lotan I; Brody J; Chodick G; Bialer O; Marignier R; Bach M; Hellmann MA PLoS One; 2017; 12(1):e0170847. PubMed ID: 28125740 [TBL] [Abstract][Full Text] [Related]
14. [Effects of intravenous methylprednisolone pulse therapy on optic neuritis associated with AQP4 antibody seropositive neuromyelitis optica]. Guo ST; Li Z; Jiang LB; Wu RH; Peng JT; Wang JW; Wei WB Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):180-185. PubMed ID: 30841684 [No Abstract] [Full Text] [Related]
15. Clinical characteristics of myelin oligodendrocyte glycoprotein seropositive optic neuritis: a cohort study in Shanghai, China. Zhao G; Chen Q; Huang Y; Li Z; Sun X; Lu P; Yan S; Wang M; Tian G J Neurol; 2018 Jan; 265(1):33-40. PubMed ID: 29101456 [TBL] [Abstract][Full Text] [Related]
16. The clinical spectrum associated with myelin oligodendrocyte glycoprotein antibodies (anti-MOG-Ab) in Thai patients. Siritho S; Sato DK; Kaneko K; Fujihara K; Prayoonwiwat N Mult Scler; 2016 Jun; 22(7):964-8. PubMed ID: 26498263 [TBL] [Abstract][Full Text] [Related]
17. Isolated new onset 'atypical' optic neuritis in the NMO clinic: serum antibodies, prognoses and diagnoses at follow-up. Piccolo L; Woodhall M; Tackley G; Juryńczyk M; Kong Y; Domingos J; Gore R; Vincent A; Waters P; Leite MI; Palace J J Neurol; 2016 Feb; 263(2):370-379. PubMed ID: 26668077 [TBL] [Abstract][Full Text] [Related]
18. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. Kitley J; Waters P; Woodhall M; Leite MI; Murchison A; George J; Küker W; Chandratre S; Vincent A; Palace J JAMA Neurol; 2014 Mar; 71(3):276-83. PubMed ID: 24425068 [TBL] [Abstract][Full Text] [Related]
19. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients. Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529 [TBL] [Abstract][Full Text] [Related]
20. Is Asian type MS an MS phenotype, an NMO spectrum disorder, or a MOG-IgG related disease? Papais Alvarenga RM; Araújo ACRAE; Nascimento ACB; Araujo NEC; Meneguette NS; Neri VC; Papais Alvarenga M; Filho HA; Barros PO; Bento CA; Schmidt SL; Vasconcelos CCF; Alvarenga MP Mult Scler Relat Disord; 2020 Jul; 42():102082. PubMed ID: 32361664 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]